Pro. Shen Ziyu is the Chairman of the Laboratory Diagnosis and Social Service Committee of the China Health Culture Association, Vice Chairman of the Clinical Laboratory Management Committee of the Chinese Hospital Association, Vice Chairman of Clinical Application of Biochemistry and Molecular Biology Division with Chinese Society of Biochemistry and Molecular Biology. He is currently the Deputy Dean of the Kingmed School of Laboratory Medicine of Guangzhou Medical University.

Dr. Yu is a certified Clinical Cytogeneticist and a fellow of American College of Medical Genetics and Genomics (FACMG). He was one of the pioneers using microarray-based Comparative Genomic Hybridization for clinical applications and his teams identified several genomic disorders for the first time in the world. He served as the director of Clinical Genetic/Genomic Testing Laboratories in Seattle Children’s Hospital, and a professor of University of Washington School of Medicine. He is currently a professor of Guangzhou Medical University, a specially appointed professor and a doctoral supervisor of Harbin Medical University.

Mr. Ren is a member of the Standing Committee of the Chinese Society of Laboratory Medicine Management within the Chinese Hospital Association. He is a former member of the standing committee of the Chinese Society of Laboratory Medicine, of which he is the ex-head of the Microbiology Branch , a member of the standing committee of the Chinese Society of Laboratory Physicians, and slao the former Chairman of Shaanxi Society of Laboratory Medicine and the Director of Shaanxi Laboratory Medicine Quality Control Center.

Dr. Fang is certified in clinical molecular genetics by the American Board of Medical Genetics and Genomics (ABMGG) and is a Fellow of American College of Medical Genetics and Genomics (FACMG). Dr. Fang was an associate professor in the department of molecular and human genetics of Baylor College of Medicine, and served as a director of the DNA diagnostic laboratory. Her clinical and research activities have been focused on molecular diagnosis of rare diseases, population carrier screening, pharmacogenomics, personalized medicine and genetic counseling.

Dr. Tan is a certified pathologist in US. His specialties include Pathology and Oncology. He currently serves as a professor of Pathology and GI Oncology in The UT MD Anderson Cancer Center.

Dr. Huang is a world-renowned surgical pathologist. His clinical expertise is in the pathologic diagnosis of genitourinary tumors. He currently serves as a professor and the chair of the Department of Pathology at Duke University School of Medicine.

Currently Dr. Wang serves as Diretor of Clinical Laboratories at Akron Children's Hospital. He is a member of the American Association for Clinical Chemistry (AACC) since 2000. He served as Section Head and Medical Director of Clinical Biochemistry and Director of Clinical Biochemistry Fellowship Training Program at Cleveland Clinic. He served as chair of AACC Northeast Ohio Section in 2008 and 2009 and the president of North American Chinese Clinical Chemistry Association (NACCCA) 2008-2009. He served as historian for NACCCA, treasurer for AACC Pediatric and Maternal Fetal division, secretary for AACC Clinical Translational Sciences division, delegate for AACC Northeast Ohio section, commissioner for the Commission on Accreditation in Clinical Chemistry (ComACC), and member of AACC's Strategies Online Editorial Advisory Board.

Professor Zhu is a well-known lymphoma pathologist with Special Government Allowance from the State Council. He has received the title of "An Expert of Outstanding Contributions" from the Pathological Society of the Chinese Medical Association.